Cargando…
Health Plan Approach to Operationalizing a Specialty Drug Management Program
BACKGROUND: Expenditures related to specialty drugs consume a significant percentage of available health care resources. OBJECTIVES: Explain the process of transitioning the management of specialty drugs from medical services to pharmacy services in 2 managed care plans and provide insight into the...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437336/ https://www.ncbi.nlm.nih.gov/pubmed/18507510 http://dx.doi.org/10.18553/jmcp.2008.14.S4-A.17 |
_version_ | 1785092498719244288 |
---|---|
author | Tegenu, Mesfin |
author_facet | Tegenu, Mesfin |
author_sort | Tegenu, Mesfin |
collection | PubMed |
description | BACKGROUND: Expenditures related to specialty drugs consume a significant percentage of available health care resources. OBJECTIVES: Explain the process of transitioning the management of specialty drugs from medical services to pharmacy services in 2 managed care plans and provide insight into the issues encountered and solutions implemented based on 6 years of experience using traditional and innovative pharmacy utilization management tools to insure appropriate specialty drug use and reimbursement. SUMMARY: The level of involvement in a specialty management program varies from managing only products dispensed by the retail, mail, and specialty pharmacy vendor to encompassing a broad list of specialty drugs distributed through a variety of channels. Efficient administrative, operational, and clinical processes are critical to the success of the program. Additionally, an accurate and timely claims processing procedure is also essential for success as is the ability to mine data and effectively report on the use of specialty products. A clinically sound, cost-effective, and patient-friendly program requires input from health plan members, pharmacy service leaders, and physician providers, and must overcome challenges associated with disrupting current relationships and removing competing incentives. CONCLUSIONS: A well-constructed and properly funded specialty drug management program results in clinical and financial benefits for the plan. |
format | Online Article Text |
id | pubmed-10437336 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Academy of Managed Care Pharmacy |
record_format | MEDLINE/PubMed |
spelling | pubmed-104373362023-08-21 Health Plan Approach to Operationalizing a Specialty Drug Management Program Tegenu, Mesfin J Manag Care Pharm Cea BACKGROUND: Expenditures related to specialty drugs consume a significant percentage of available health care resources. OBJECTIVES: Explain the process of transitioning the management of specialty drugs from medical services to pharmacy services in 2 managed care plans and provide insight into the issues encountered and solutions implemented based on 6 years of experience using traditional and innovative pharmacy utilization management tools to insure appropriate specialty drug use and reimbursement. SUMMARY: The level of involvement in a specialty management program varies from managing only products dispensed by the retail, mail, and specialty pharmacy vendor to encompassing a broad list of specialty drugs distributed through a variety of channels. Efficient administrative, operational, and clinical processes are critical to the success of the program. Additionally, an accurate and timely claims processing procedure is also essential for success as is the ability to mine data and effectively report on the use of specialty products. A clinically sound, cost-effective, and patient-friendly program requires input from health plan members, pharmacy service leaders, and physician providers, and must overcome challenges associated with disrupting current relationships and removing competing incentives. CONCLUSIONS: A well-constructed and properly funded specialty drug management program results in clinical and financial benefits for the plan. Academy of Managed Care Pharmacy 2008-05 /pmc/articles/PMC10437336/ /pubmed/18507510 http://dx.doi.org/10.18553/jmcp.2008.14.S4-A.17 Text en Copyright © 2008, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Cea Tegenu, Mesfin Health Plan Approach to Operationalizing a Specialty Drug Management Program |
title | Health Plan Approach to Operationalizing a Specialty Drug Management Program |
title_full | Health Plan Approach to Operationalizing a Specialty Drug Management Program |
title_fullStr | Health Plan Approach to Operationalizing a Specialty Drug Management Program |
title_full_unstemmed | Health Plan Approach to Operationalizing a Specialty Drug Management Program |
title_short | Health Plan Approach to Operationalizing a Specialty Drug Management Program |
title_sort | health plan approach to operationalizing a specialty drug management program |
topic | Cea |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437336/ https://www.ncbi.nlm.nih.gov/pubmed/18507510 http://dx.doi.org/10.18553/jmcp.2008.14.S4-A.17 |
work_keys_str_mv | AT tegenumesfin healthplanapproachtooperationalizingaspecialtydrugmanagementprogram |